Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

Walgreens Boots Alliance, Inc. (WBA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 10-K Annual Report for the period ended August 31, 2023
10/12/2023 8-K Quarterly results
10/11/2023 8-K Quarterly results
10/10/2023 SC 13G/A VANGUARD GROUP INC reports a 10% stake in Walgreens Boots Alliance Inc.
08/09/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Delayed Draw Term Loan Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent",
"Three-Year Revolving Credit Agreement, by and among Walgreens Boots Alliance, Inc., the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent and Swing Line Lender"
08/07/2023 4 Walgreens Boots Alliance, Inc. (10% Owner) has filed a Form 4 on AMERISOURCEBERGEN CORP
Txns: Sold 1,320,858 shares @ $189.271, valued at $250M
Acquired 262,500 options to buy @ $0
Acquired 525,000 options to buy @ $0
Acquired 1,050,000 options to buy @ $0
Acquired 1,312,500 options to buy @ $0
Acquired 1,575,000 options to buy @ $0
Acquired 2,625,000 options to buy @ $0
08/07/2023 3 Heckman Todd (Interim Global Controller) has filed a Form 3 on Walgreens Boots Alliance, Inc.
08/07/2023 SC 13D/A Walgreens Boots Alliance, Inc. reports a 15.8% stake in AMERISOURCEBERGEN CORPORATION
07/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Walgreens Boots Alliance Announces CFO Transition"
07/14/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2023 8-K Quarterly results
07/05/2023 4 DRISCOLL JOHN PATRICK (EVP, Pres. U.S. Healthcare) has filed a Form 4 on Walgreens Boots Alliance, Inc.
Txns: Bought 5,172 shares @ $28.4191, valued at $147k
06/15/2023 144 Form 144 - Report of proposed sale of securities:
06/12/2023 SC 13D/A Walgreens Boots Alliance, Inc. reports a 0% stake in Option Care Health, Inc.
06/08/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Stipulation of Settlement",
"Amended Notice of Pendency and Proposed Settlement of Shareholder Derivative Action, preliminarily approved May 8, 2023"
05/15/2023 4 Walgreens Boots Alliance, Inc. (10% Owner) has filed a Form 4 on AMERISOURCEBERGEN CORP
Txns: Sold 292,792 shares @ $170.77, valued at $50M
Disposed of 918,000 options to buy @ $0
Disposed of 1,836,000 options to buy @ $0
05/15/2023 SC 13D/A Walgreens Boots Alliance, Inc. reports a 16.5% stake in AMERISOURCEBERGEN CORPORATION
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/03/2023 4 Kehoe James (EVP and Global CFO) has filed a Form 4 on Walgreens Boots Alliance, Inc.
Txns: Paid exercise price by delivering 6,020 shares @ $35.25, valued at $212.2k
05/01/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/31/2023 4 BREWER ROSALIND G (CEO) has filed a Form 4 on Walgreens Boots Alliance, Inc.
Txns: Bought 10,000 shares @ $33.951, valued at $339.5k
03/28/2023 10-Q Quarterly Report for the period ended February 28, 2023
03/28/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/21/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Summit Health-CityMD unaudited supplemental financial information",
"Summit Health-CityMD unaudited supplemental financial information"
03/21/2023 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of PricewaterhouseCoopers LLP, independent auditor of Summit Health-CityMD",
"Summit Health-CityMD Audited Consolidated Financial Statements as of December 31, 2021 and for the year ended December 31, 2021",
"Summit Health-CityMD Unaudited Condensed Consolidated Financial Statements as of and for the nine months ended September 30, 2022",
"Unaudited Pro Forma Condensed Combined Financial Information consisting of the Unaudited Pro Forma Condensed Combined Balance Sheet as of November 30, 2022, the Unaudited Pro Forma Condensed Combined Statement of Earnings for the year ended August 31, 2022 and the Unaudited Pro Forma Condensed Combined Statement of Earnings for the three months ended November 30, 2022"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy